Publikationen

100.
Scholtysek C, Katzenbeisser J, Fu H, Uderhardt S, Ipseiz N, Stoll C, Zaiss MM, Stock M, Donhauser L, Böhm C, Kleyer A, Hess A, Engelke K, David J, Djouad F, Tuckermann JP, Desvergne B, Schett G, Krönke G. PPAR\textgreekb/\textgreekd governs Wnt signaling and bone turnover. Nature medicine. 2013; 19(5):608—613.      [DOI] 
99.
Zee T, Boller S, Györy I, Makinistoglu MP, Tuckermann JP, Grosschedl R, Karsenty G. The transcription factor early B-cell factor 1 regulates bone formation in an osteoblast-nonautonomous manner. FEBS letters. 2013; 587(6):711—716.      [DOI] 
98.
Zee T, Boller S, Györy I, Makinistoglu MP, Tuckermann JP, Grosschedl R, Karsenty G. The transcription factor early B-cell factor 1 regulates bone formation in an osteoblast-nonautonomous manner. FEBS letters. 2013; 587(6):711—716.      [DOI] 
97.
Zee T, Boller S, Györy I, Makinistoglu MP, Tuckermann JP, Grosschedl R, Karsenty G. The transcription factor early B-cell factor 1 regulates bone formation in an osteoblast-nonautonomous manner. FEBS letters. 2013; 587(6):711—716.      [DOI] 
96.
Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. American journal of physiology. Endocrinology and metabolism. 2012; 302(10):E1210-20.      [DOI] 
95.
Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. American journal of physiology. Endocrinology and metabolism. 2012; 302(10):E1210-20.      [DOI] 
94.
Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. American journal of physiology. Endocrinology and metabolism. 2012; 302(10):E1210-20.      [DOI] 
93.
Illing A, Liu P, Ostermay S, Schilling A, Haan G, Krust A, Amling M, Chambon P, Schinke T, Tuckermann JP. Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone. Haematologica. 2012; 97(8):1131—1135.      [DOI] 
92.
Illing A, Liu P, Ostermay S, Schilling A, Haan G, Krust A, Amling M, Chambon P, Schinke T, Tuckermann JP. Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone. Haematologica. 2012; 97(8):1131—1135.      [DOI] 
91.
Illing A, Liu P, Ostermay S, Schilling A, Haan G, Krust A, Amling M, Chambon P, Schinke T, Tuckermann JP. Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone. Haematologica. 2012; 97(8):1131—1135.      [DOI] 
90.
Kleiman A, Hübner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, Bauer M, Schmid W, Schütz G, Libert C, Reichardt HM, Tuckermann JP. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012; 26(2):722—729.      [DOI] 
89.
Kleiman A, Hübner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, Bauer M, Schmid W, Schütz G, Libert C, Reichardt HM, Tuckermann JP. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012; 26(2):722—729.      [DOI] 
88.
Kleiman A, Hübner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, Bauer M, Schmid W, Schütz G, Libert C, Reichardt HM, Tuckermann JP. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012; 26(2):722—729.      [DOI] 
87.
Reichardt SD, Föller M, Rexhepaj R, Pathare G, Minnich K, Tuckermann JP, Lang F, Reichardt HM. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes. Endocrinology. 2012; 153(4):1783—1794.      [DOI] 
86.
Reichardt SD, Föller M, Rexhepaj R, Pathare G, Minnich K, Tuckermann JP, Lang F, Reichardt HM. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes. Endocrinology. 2012; 153(4):1783—1794.      [DOI] 
85.
Reichardt SD, Föller M, Rexhepaj R, Pathare G, Minnich K, Tuckermann JP, Lang F, Reichardt HM. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes. Endocrinology. 2012; 153(4):1783—1794.      [DOI] 
84.
Mueller KM, Themanns M, Friedbichler K, Kornfeld J, Esterbauer H, Tuckermann JP, Moriggl R. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Molecular and cellular endocrinology. 2012; 361(1-2):1—11.      [DOI] 
83.
Mueller KM, Themanns M, Friedbichler K, Kornfeld J, Esterbauer H, Tuckermann JP, Moriggl R. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Molecular and cellular endocrinology. 2012; 361(1-2):1—11.      [DOI] 
82.
Mueller KM, Themanns M, Friedbichler K, Kornfeld J, Esterbauer H, Tuckermann JP, Moriggl R. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Molecular and cellular endocrinology. 2012; 361(1-2):1—11.      [DOI] 
81.
Kleyer A, Scholtysek C, Bottesch E, Hillienhof U, Beyer C, Distler JH, Tuckermann JP, Schett G, Krönke G. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012; 27(12):2442—2451.      [DOI] 
80.
Kleyer A, Scholtysek C, Bottesch E, Hillienhof U, Beyer C, Distler JH, Tuckermann JP, Schett G, Krönke G. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012; 27(12):2442—2451.      [DOI] 
79.
Kleyer A, Scholtysek C, Bottesch E, Hillienhof U, Beyer C, Distler JH, Tuckermann JP, Schett G, Krönke G. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012; 27(12):2442—2451.      [DOI] 
78.
Böhm C, Derer A, Axmann R, Hillienhoff U, Zaiss MM, Luther J, Zech C, Stock M, Scholtysek C, Engelke K, Hess A, Tuckermann JP, Schett G, David J. RSK2 protects mice against TNF-induced bone loss. Journal of cell science. 2012; 125(Pt 9):2160—2171.      [DOI] 
77.
Böhm C, Derer A, Axmann R, Hillienhoff U, Zaiss MM, Luther J, Zech C, Stock M, Scholtysek C, Engelke K, Hess A, Tuckermann JP, Schett G, David J. RSK2 protects mice against TNF-induced bone loss. Journal of cell science. 2012; 125(Pt 9):2160—2171.      [DOI] 
76.
Böhm C, Derer A, Axmann R, Hillienhoff U, Zaiss MM, Luther J, Zech C, Stock M, Scholtysek C, Engelke K, Hess A, Tuckermann JP, Schett G, David J. RSK2 protects mice against TNF-induced bone loss. Journal of cell science. 2012; 125(Pt 9):2160—2171.      [DOI]